Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sotatercept for chemotherapy-induced anemia in solid tumors
NCT01284348Phase 2Terminated
- Sponsor
- Merck & Co.
- Start
- Mar 2011
- Primary completion
- Sep 2012
- Modality
- Fc-Fusion Proteins
01
Overview
A Phase 2 trial of sotatercept in Chemotherapy-induced anemia (CIA), sponsored by Merck & Co.. Started Mar 2011; status: terminated.
02
Drugs
sotatercept
03
Conditions
Chemotherapy-induced anemia (CIA)
Beyond the preview
Go deeper on NCT01284348.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01284348.